BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Waijer SW, Provenzano M, Mulder S, Rossing P, Persson F, Perkovic V, Heerspink HJL. Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrology. Diabetes Obes Metab 2022;24:983-90. [PMID: 35112455 DOI: 10.1111/dom.14660] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Li MH, Guan J, Chen Z, Mo JX, Wu KR, Hu XG, Lan T, Guo J. Fufang Zhenzhu Tiaozhi capsule ameliorates hyperuricemic nephropathy by inhibition of PI3K/AKT/NF-κB pathway. J Ethnopharmacol 2022;298:115644. [PMID: 35987412 DOI: 10.1016/j.jep.2022.115644] [Reference Citation Analysis]
2 Miyamoto S, Heerspink HJL, de Zeeuw D, Toyoda M, Suzuki D, Hatanaka T, Nakamura T, Kamei S, Murao S, Hida K, Ando S, Akai H, Takahashi Y, Koya D, Kitada M, Sugano H, Nunoue T, Nakamura A, Sasaki M, Nakatou T, Fujimoto K, Kawanami D, Wada T, Miyatake N, Yoshida M, Shikata K; CANPIONE study Investigators. Rationale, design and baseline characteristics of the effect of canagliflozin in patients with type 2 diabetes and microalbuminuria in the Japanese population: The CANPIONE study. Diabetes Obes Metab 2022;24:1429-38. [PMID: 35491532 DOI: 10.1111/dom.14731] [Reference Citation Analysis]